Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial

被引：0
|
作者：
Ashkan Emadi
Joel V. Chua
Rohit Talwani
Søren M. Bentzen
John Baddley
机构：
[1] University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,
[2] University of Maryland School of Medicine Department of Medicine,undefined
[3] University of Maryland School of Medicine Department of Pharmacology,undefined
[4] University of Maryland School of Medicine,undefined
[5] Institute of Human Virology,undefined
[6] University of Maryland School of Medicine Department of Epidemiology and Public Health,undefined
来源：
Trials | / 21卷
关键词：
COVID-19; Randomised controlled trial; protocol; SARS-CoV; imatinib; tyrosine kinase inhibitor; TKI; lysosomal sequestration; viral ABL-1 signalling; TKI-induced attenuation of vascular leak; TKI-induced prevention and treatment lung inflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
    Emadi, Ashkan
    Chua, Joel V.
    Talwani, Rohit
    Bentzen, Soren M.
    Baddley, John
    [J]. TRIALS, 2020, 21 (01)
  • [2] The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
    Samimagham, Hamid Reza
    Azad, Mehdi Hassani
    Haddad, Maryam
    Arabi, Mohsen
    Hooshyar, Dariush
    KazemiJahromi, Mitra
    [J]. TRIALS, 2020, 21 (01)
  • [3] The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
    Hamid Reza Samimagham
    Mehdi Hassani Azad
    Maryam Haddad
    Mohsen Arabi
    Dariush Hooshyar
    Mitra KazemiJahromi
    [J]. Trials, 21
  • [4] A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial
    Bosaeed, Mohammad
    Mahmoud, Ebrahim
    Hussein, Mohammad
    Alharbi, Ahmad
    Alsaedy, Abdulrahman
    Alothman, Adel
    Aljeraisy, Majed
    Alqahtani, Hajar
    Nashabat, Marwan
    Almutairi, Badriah
    Almaghaslah, Manar
    Aldibasi, Omar
    AlJohani, Sameera
    Bouchama, Abderrezak
    Arabi, Yaseen
    Alaskar, Ahmad
    [J]. TRIALS, 2020, 21 (01)
  • [5] A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial
    Mohammad Bosaeed
    Ebrahim Mahmoud
    Mohammad Hussein
    Ahmad Alharbi
    Abdulrahman Alsaedy
    Adel Alothman
    Majed Aljeraisy
    Hajar Alqahtani
    Marwan Nashabat
    Badriah Almutairi
    Manar Almaghaslah
    Omar Aldibasi
    Sameera AlJohani
    Abderrezak Bouchama
    Yaseen Arabi
    Ahmad Alaskar
    [J]. Trials, 21
  • [6] Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
    Hamid Reza Samimagham
    Mehdi Hassani Azad
    Dariush Hooshyar
    Maryam Haddad
    Mohsen Arabi
    Mitra KazemiJahromi
    [J]. Trials, 22
  • [7] Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
    Samimagham, Hamid Reza
    Azad, Mehdi Hassani
    Hooshyar, Dariush
    Haddad, Maryam
    Arabi, Mohsen
    KazemiJahromi, Mitra
    [J]. TRIALS, 2021, 22 (01)
  • [8] The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
    Rahimi, Arash
    Samimagham, Hamid Reza
    Azad, Mehdi Hassani
    Hooshyar, Dariush
    Arabi, Mohsen
    KazemiJahromi, Mitra
    [J]. TRIALS, 2021, 22 (01)
  • [9] The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
    Arash Rahimi
    Hamid Reza Samimagham
    Mehdi Hassani Azad
    Dariush Hooshyar
    Mohsen Arabi
    Mitra KazemiJahromi
    [J]. Trials, 22
  • [10] The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial
    Fatemeh Sadat Hosseini
    Alireza Malektojari
    Sara Ghazizadeh
    Mehdi Hassaniazad
    Parivash Davoodian
    Habib Dadvand
    Amin Reza Nikpoor
    Sara Nikoofal-Sahlabadi
    Sara Kahoori
    Mojtaba Sepandi
    Soheil Hassanipour
    Mohammad Fathalipour
    [J]. Trials, 22
12345